Pepin E, Jalinier T, Lemieux GL</u, Massicotte G and Cyr M (2020) Sphingosine 1-phosphate receptors modulators decrease neuroinflammation and prevent Parkinson’s disease symptoms in the MPTP mouse model. Frontiers in Pharmacology; fphar.2020.00077
Ouimet B, Pépin É, Bergeron Y, Chagniel L, Beaulieu JM, Massicotte G, Cyr M (2019). Motor learning deficits and striatal GSK-3 hyperactivity in Akt3 knockout mice. Behav Neurosci.;133(1):135-143
Hernandez G, Mahmoudi S, Cyr M, Diaz J, Blanchet PJ, Lévesque D (2019). Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates. Movement Disorders; 34(5):717-726
Bergeron Y, Bureau G, Laurier-Laurin ME, Asselin E, Massicotte G, Cyr M. (2017). Genetic Deletion of Akt3 Induces an Endophenotype Reminiscent of Psychiatric Manifestations in Mice. Frontier in molecular neuroscience. fnmol.2017.00102
St-Cyr Giguère F, Attiori Essis S, Chagniel L, Germain M, Cyr M, Massicotte G. (2017) The sphingosine-1-phosphate receptor 1 agonist SEW2871 reduces Tau-Ser262 phosphorylation in rat hippocampal slices. Brain Res. 1658:51-59
Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, Cyr M, and Salahpour A, (2015) Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiol Dis. 74:66-75
Essis SA, Laurier-Laurin ME, Pépin É, Cyr M, Massicotte G. (2015) GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P. Brain Res. doi: 10.1016/j.brainres.2015.07.055.